Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07347106 · ClinicalTrials.gov registry record · NA
Miro3D Randomized Controlled Trial (RCT)
A NA study of Wound, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT07347106: Recruiting NA study of Wound, sponsored by Washington University School of Medicine.
NCT07347106 is a NA study of Wound that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 70 participants, below the 417-participant average among 8 other Wound trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07347106, a NA study of Wound, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the outcomes for patients managed with standard of care (SOC) wound treatments and those managed with standard of care treatment and tissue scaffolds, specifically Miro 3D. Tissue scaffolds like Miro 3D are 3-dimentional frameworks for collagen protein that provide structure and protection to help wounds heal.
Primary Outcome
Rate of change
Conditions Studied
Interventions
- OTHER Standard of Care Treatment or Standard of Care Treatment plus Miro3D Wound Matrix
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-01 |
| Est. Completion | 2028-07 |
| Phase | NA |
What NCT07347106 shows while recruiting
NCT07347106 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 417-participant average among 8 other Wound trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Wound appearing as the primary indexed condition, and to 1 intervention - of which Standard of Care Treatment or Standard of Care Treatment plus Miro3D Wound Matrix is the first listed.
NCT07347106 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT07347106 about?
NCT07347106 is a clinical study titled "Miro3D Randomized Controlled Trial (RCT)". The purpose of this research study is to evaluate the outcomes for patients managed with standard of care (SOC) wound treatments and those managed with standard of care treatment and tissue scaffolds, specifically Miro 3D. Tissue scaffolds like Miro 3D are 3-dimentional frameworks for collagen prote...
What is the current status of trial NCT07347106?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-01. Estimated completion is 2028-07.
What conditions does trial NCT07347106 study?
This clinical trial studies the following conditions: Wound.
What interventions are being tested in trial NCT07347106?
The interventions under investigation include: Standard of Care Treatment or Standard of Care Treatment plus Miro3D Wound Matrix (OTHER).
Who is sponsoring clinical trial NCT07347106?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07347106 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07347106's enrollment target sits among peer trials
70 6th of 8 higher than 3 of 8 other Wound trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing
RECRUITING · NA
-
Diabetic Foot Ulcer (DFU) Rapid Pathogen Identification
COMPLETED · NA
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Novel Strategies for Reducing Burn Scar Itch
RECRUITING · Phase 3
-
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
RECRUITING · Phase 3
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia